Details
Description
Inclusion Criteria
Exclusion Criteria
Details
Title A Randomized Phase II/III Study to Assess the Efficacy of Trametinib (GSK 1120212) in Patients with Recurrent or Progressive Low-Grade Serous Ovarian Cancer or Peritoneal Cancer
IRB GOG0281
CC 15-481
Hospital Fairview, Hillcrest, Main Campus
Phase Phase 2, Phase 3
Disease Gynecologic, Ovarian, Peritoneal
Drug Trametinib
